The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Is The Forecasted Market Value Of The Nucleic Acid Labeling Market Across 2026–2030?
The nucleic acid labeling market size has experienced robust growth in recent years. It is forecast to increase from $2.77 billion in 2025 to $3.03 billion in 2026, driven by a compound annual growth rate (CAGR) of 9.4%. The market’s historic expansion can be linked to factors such as the limited availability of sensitive labeling reagents, low awareness of nucleic acid labeling applications, the high cost of instruments, reliance on traditional labeling methods, and the slow adoption of high-throughput technologies.
The nucleic acid labeling market is projected to experience robust expansion over the coming years. This market is forecast to reach $4.42 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 9.9%. This projected expansion is primarily driven by improvements in fluorescent and non-radioactive labeling technologies, heightened research and development activities in genomics and molecular diagnostics, a growing need for high-throughput and multiplex assays, increased integration into hospitals and diagnostic facilities, and greater investment in research endeavors. Key developments anticipated during this timeframe involve the wider acceptance of nucleic acid labeling methodologies, the continuous creation of sophisticated labeling kits and reagents, expanding utility across diagnostic and research domains, a sharpened emphasis on multiplex and high-throughput labeling approaches, and enhanced integration of imaging with analytical instrumentation.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12647&type=smp
Which Market Drivers Are Supporting The Expansion Of The Nucleic Acid Labeling Market?
The nucleic acid labeling market is projected to expand with the continuing increase in infectious diseases. These diseases are characterized as conditions caused by microscopic organisms such as viruses, bacteria, fungi, and parasites, which spread between individuals through either direct or indirect contact. Nucleic acid labeling techniques improve the detection of infectious diseases like tuberculosis, hepatitis, and gonorrhea by offering enhanced specificity, sensitivity, multiplexing capabilities, visualization, real-time monitoring, and automation. For example, in March 2024, the Centers for Disease Control and Prevention, a US-based national public health agency, reported that tuberculosis (TB) cases had risen by 1,295, increasing from 8,320 in 2022 to 9,615 in 2023. This also led to an increase in the incidence rate from 2.5 per 100,000 persons in 2022 to 2.9 per 100,000 in 2023, signifying a considerable year-on-year growth. Consequently, the escalation of infectious diseases is a driving force for the growth of the nucleic acid labeling market.
What Segmentation Levels Are Considered In The Nucleic Acid Labeling Market?
The nucleic acid labeling market covered in this report is segmented –
1) By Product Type: Kits, Reagents, Instruments
2) By Labeling Type: Radioisotope Or Radioactive Labels, Non-Radioactive Labels
3) By Method: Enzyme-Based, Chemical-Based
4) By Application: DNA Sequencing, Polymerase Chain Reaction, Fluorescence In Situ Hybridization (FISH), Microarrays, Blotting, In Situ Hybridization, Other Applications
5) By End-User: Hospitals Or Clinics, Diagnostic Centers, Other End-Users
Subsegments:
1) By Kits: DNA Labeling Kits, RNA Labeling Kits, Multiplex Labeling Kits
2) By Reagents: Labeling Reagents, Buffer Solutions, Conjugation Reagents
3) By Instruments: Nucleic Acid Analyzers, Microarray Processors, Imaging Systems
What Trends Are Projected To Affect The Nucleic Acid Labeling Market?
Leading firms within the nucleic acid labeling market are allocating resources to enhance their financial gains within this sector. Investments in nucleic acid labelling signify monetary commitments, capital provision, or financing infusion from various sources, including individuals, institutions, or venture capitalists, directed towards ventures, businesses, or endeavors associated with nucleic acid labeling technologies, research, and development. As an illustration, during January 2023, Agilent Technologies Inc., a US-based supplier of software and instruments for laboratories, committed $725 million to double its production capability for therapeutic nucleic acids, addressing the escalating need for premium active pharmaceutical ingredients. This expansion, which aligns with the company’s strategic emphasis on thriving markets, is designed to satisfy the growing requirements for siRNA, antisense, and CRISPR guide RNA molecules employed in medicines targeting a variety of ailments including cancer, cardiovascular problems, and both rare and infectious conditions.
Which Leading Firms Are Contributing To The Growth Of The Nucleic Acid Labeling Market?
Major companies operating in the nucleic acid labeling market are Thermo Fisher Scientific Inc., Merck Group, Roche Diagnostics Corporation, GE Healthcare Bio Sciences AB, Agilent Technologies Inc., PerkinElmer Inc., Bio-Rad Laboratories Inc., Cytiva, Qiagen N.V., Biotium Inc., Illumina Inc., LGC Group, Promega Corporation, New England Biolabs, Enzo Biochem Inc., LI-COR Biosciences Inc., Eurogentec S.A., OriGene Technologies Inc., BaseClear B.V., Vector Laboratories Inc., Bio-Synthesis Inc., BioCat GmbH, Jena Bioscience GmbH, LubioScience GmbH, GeneCopoeia Inc., Mirus Bio LLC, Daicel Arbor Biosciences
Read the full nucleic acid labeling market report here:
https://www.thebusinessresearchcompany.com/report/nucleic-acid-labeling-global-market-report
How Is The Nucleic Acid Labeling Market Distributed Across Key Geographic Regions?
North America was the largest region in the nucleic acid labeling market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the nucleic acid labeling market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Nucleic Acid Labeling Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=12647&type=smp
Browse Through More Reports Similar to the Global Nucleic Acid Labeling Market 2026, By The Business Research Company
Genes Therapy Global Market Report
https://www.thebusinessresearchcompany.com/report/genes-therapy-global-market-report
Oligonucleotides Therapy Global Market Report
https://www.thebusinessresearchcompany.com/report/oligonucleotides-therapy-global-market-report
Ribose Nucleic Acid Rna Based Therapeutics Global Market Report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model